In This Section      
Print This Page

Meet Our Fellows: Johns Hopkins Sidney Kimmel Comprehensive Cancer Center

null

Class Entering 2017

  • Wei-Ming Kao, MD, PhD
  • Emily Limerick, MD
  • Matthew Merguerian, MD, PhD
  • Patience Obasaju, MD
  • Russell “Taylor” Sundby, MD
  • Kristin Wessel, MD

Learn more.

Class Entering 2016

  • Andrea Cuviello, MD
  • Julia Cohen, MD
  • Yiouli Ktena, MD
  • John Ligon, MD
  • Lei Peng, MD
  • Shubin Shahab, MD, PhD

Class Entering 2015

  • Lingling “Lynn” Chen, MD
    Mentor: Drew Pardoll, MD, PhD 
    Project: Tumor microenvironment and tumor infiltrating cells in alveolar rhabdomyosarcoma
     
  • John LeGall, MD, MBA, MS
    Mentor: Luca Gattinoni, MD
    Project: C-myb in memory T cell differentiation and chimeric antigen receptors
     
  • Kathryn Lemberg, MD, PhD
    Mentor: Barbara Slusher, PhD, MAS
    Project: Glutamine metabolism in tumors associated with neurofibromatosis-1
     
  • Micah Maxwell, MD, PhD
    Mentor: Eric Raabe, MD, PhD
    Project: LIN28A and LIN28B in pediatric brain tumors
     
  • Sneha Ramakrishna, MD
    Mentor: Terry Fry, MD
    Project: Chimeric antigen receptor therapy for acute leukemias
     
  • Kristen Schratz, MD
    Mentor: Mary Armanios, MD
    Project: Telomeres and oncogenesis

Class Entering 2014

  • Alissa Baker, MD
    Mentor: David Loeb, MD, PhD
     Project: Palmitoylation in Wnt-signaling of Ewing sarcoma
     
  • Thomas Fountaine, MD
    Mentor: Jack Shern, MD
    Project: Genomics of patients treated with chimeric antigen receptors
     
  • Eric Kohler, MD, PhD
    Mentor: Terry Fry, MD
    Project: Chimeric antigen receptors in acute myeloid leukemia
     
  • Michael Koldobskiy, MD, PhD
    Mentor: Andrew Feinberg, MD, MPH
    Project: DNA methylation in pre-B acute lymphoblastic leukemia
     
  • Bonnie Lau, MD, PhD
    Mentor: William Matsui, MD
    Project: Stem cells in bone marrow failure syndromes
     
  • David Young, MD, PhD
    Mentor: Donald Small, MD, PhD
    Project: A novel therapeutic agent targeting FLT3-ITD acute myeloid leukemia